2014Nanomedicine journalOpen access

THE EFFECTS OF ZINC OXIDE NANOPARTICLES ON DIFFERENTIATION OF HUMAN MESENCHYMAL STEM CELLS TO OSTEOBLAST

Tahereh Foroutan

Open full text 18 citations

Abstract

Objective(s):The mesenchymal stem cells (MSCs) have been introduced as appropriate cells for tissue engineering and medical applications. Some studies have shown that topography of materials especially physical surface characteristics and particles size could enhance adhesion and proliferation of osteoblasts. In the present research, we studied the distinction effect of 30 and 60 μg/ml of zinc oxide (ZnO) on differentiation of human mesenchymal stem cells to osteoblast. Materials and Methods: After the third passage, human bone marrow mesenchymal stem cells were exposed to 30 and 60 μg/ml of ZnO nanoparticles having a size of 30 nm. The control group has received no ZnO nanoparticles. On day 15 of incubation for monitoring the cellular differentiation, alizarin red staining and RT-PCR assays were performed to evaluate the level of osteopontin, osteocalsin and alkaline phosphatase genes expression.Results:In the group receiving 30 μg/ml of ZnO nanoparticles, the expression of osteogenic markers such as alkaline phosphatase, osteocalcin and osteopontin genes were significantly higher than both control and the group receiving 60 μg/ml ZnO nanoparticle. These data also confirmed by alizarin red staining.Conclusion:It seems the process of differentiation of MSCs affected by ZnO nanoparticles is dependent on dose as well as on the size of ZnO.

About this research paper

What this paper is about

Objective(s):The mesenchymal stem cells (MSCs) have been introduced as appropriate cells for tissue engineering and medical applications. Some studies have shown that topography of materials especially physical surface characteristics and particles size could enhance adhesion and proliferation of osteoblasts. In the present research, we studied the distinction effect of 30 and 60 μg/ml of zinc oxide (ZnO) on differentiation of human mesenchymal stem cells to osteoblast. Materials and Methods: After the third passage, human bone marrow mesenchymal stem cells were exposed to 30 and 60 μg/ml of ZnO nanoparticles having a size of 30 nm. The control group has received no ZnO nanoparticles. On day 15 of incubation for monitoring the cellular differentiation, alizarin red staining and RT-PCR assays were performed to evaluate the level of osteopontin, osteocalsin and alkaline phosphatase genes expression.Results:In the group receiving 30 μg/ml of ZnO nanoparticles, the expression of osteogenic markers such as alkaline phosphatase, osteocalcin and osteopontin genes were significantly higher than both control and the group receiving 60 μg/ml ZnO nanoparticle. These data also confirmed by alizarin red staining.Conclusion:It seems the process of differentiation of MSCs affected by ZnO nanoparticles is dependent on dose as well as on the size of ZnO.

Why it matters

OpenAlex reports 18 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective(s):The mesenchymal stem cells (MSCs) have been introduced as appropriate cells for tissue engineering and medical applications. Some studies have shown that topography of materials especially physical surface characteristics and particles size could enhance adhesion and proliferation of osteoblasts. In the present research, we studied the distinction effect of 30 and 60 μg/ml of zinc oxide (ZnO) on differentiation of human mesenchymal stem cells to osteoblast. Materials and Methods: After the third passage, human bone marrow mesenchymal stem cells were exposed to 30 and 60 μg/ml of ZnO nanoparticles having a size of 30 nm. The control group has received no ZnO nanoparticles. On day 15 of incubation for monitoring the cellular differentiation, alizarin red staining and RT-PCR assays were performed to evaluate the level of osteopontin, osteocalsin and alkaline phosphatase genes expression.Results:In the group receiving 30 μg/ml of ZnO nanoparticles, the expression of osteogenic markers such as alkaline phosphatase, osteocalcin and osteopontin genes were significantly higher than both control and the group receiving 60 μg/ml ZnO nanoparticle. These data also confirmed by alizarin red staining.Conclusion:It seems the process of differentiation of MSCs affected by ZnO nanoparticles is dependent on dose as well as on the size of ZnO.

Key concepts: Mesenchymal stem cell, Osteopontin, Alkaline phosphatase, Osteoblast, Osteocalcin, ALIZARIN RED, CD44, Nanoparticle

Related papers

Back to paper searchBrowse research topicsOriginal source
THE EFFECTS OF ZINC OXIDE NANOPARTICLES ON DIFFERENTIATION OF HUMAN MESENCHYMAL STEM CELLS TO OSTEOBLAST — Research Paper | ScholarLens